This brand name is authorized in Turkey
The drug BIOBER-ZN contains a combination of these active pharmaceutical ingredients (APIs):
1
Lactic acid bacteria
UNII L07O8T40TE - BIFIDOBACTERIUM BREVE
|
|
2
Lactic acid bacteria
UNII EF3U3H7I76 - BIFIDOBACTERIUM LONGUM INFANTIS
|
|
3
Lactic acid bacteria
UNII 1PRR1V42V5 - LACTOBACILLUS ACIDOPHILUS
|
|
4
Zinc sulfate
UNII N57JI2K7WP - ZINC SULFATE HEPTAHYDRATE
|
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A07FA51 | Lactic acid producing organisms, combinations | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: TR | ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu | Identifier(s): 8699591700271 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.